Radiation Exposure During Uterine Artery Embolization: Effective Measures to Minimize Dose to the Patient
- 23 August 2014
- journal article
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 38 (3) , 613-622
Abstract
Evaluation of patient radiation exposure during uterine artery embolization (UAE) and literature review to identify techniques minimizing required dose. A total of 224 of all included 286 (78 %) women underwent UAE according to a standard UAE-protocol (bilateral UAE from unilateral approach using a Rösch inferior mesenteric and a microcatheter, no aortography, no ovarian artery catheterization or embolization) and were analyzed for radiation exposure. Treatment was performed on three different generations of angiography systems: (I) new generation flat-panel detector (N = 108/151); (II) classical image amplifier and pulsed fluoroscopy (N = 79/98); (III) classical image amplifier and continuous fluoroscopy (N = 37/37). Fluoroscopy time (FT) and dose-area product (DAP) were documented. Whenever possible, the following dose-saving measures were applied: optimized source-object, source-image, and object-image distances, pulsed fluoroscopy, angiographic runs in posterior-anterior direction with 0.5 frames per second, no magnification, tight collimation, no additional aortography. In a standard bilateral UAE, the use of the new generation flat-panel detector in group I led to a significantly lower DAP of 3,156 cGy × cm2 (544–45,980) compared with 4,000 cGy × cm2 (1,400–13,000) in group II (P = 0.033). Both doses were significantly lower than those of group III with 8,547 cGy × cm2 (3,324–35,729; P < 0.001). Other reasons for dose escalation were longer FT due to difficult anatomy or a large leiomyoma load, additional angiographic runs, supplementary ovarian artery embolization, and obesity. The use of modern angiographic units with flat panel detectors and strict application of methods of radiation reduction lead to a significantly lower radiation exposure. Target DAP for UAE should be kept below 5,000 cGy × cm2.Keywords
This publication has 31 references indexed in Scilit:
- Clinical Long-term Outcome after Uterine Artery Embolization: Sustained Symptom Control and Improvement of Quality of LifeJournal of Vascular and Interventional Radiology, 2013
- Long‐term follow up after uterine artery embolization for symptomatic uterine leiomyomasActa Obstetricia et Gynecologica Scandinavica, 2011
- Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year resultsBJOG: An International Journal of Obstetrics & Gynaecology, 2011
- Long-term effects of uterine fibroid embolization on ovarian reserve: a prospective cohort studyFertility and Sterility, 2010
- Uterine Artery Embolization for Fibroids: A Review of Current OutcomesSeminars in Reproductive Medicine, 2010
- Long-term Outcome of Uterine Artery Embolization for Symptomatic Uterine LeiomyomasJournal of Vascular and Interventional Radiology, 2008
- A Prospective Multicenter Comparative Study between Myomectomy and Uterine Artery Embolization with Polyvinyl Alcohol Microspheres: Long-term Clinical Outcomes in Patients with Symptomatic Uterine FibroidsJournal of Vascular and Interventional Radiology, 2006
- Long-Term Outcome of Uterine Artery Embolization of LeiomyomataObstetrics & Gynecology, 2005
- Uterine Fibroids: Uterine Artery Embolization versus Abdominal Hysterectomy for Treatment—A Prospective, Randomized, and Controlled Clinical TrialRadiology, 2003
- Comparison of long-term outcomes of myomectomy and uterine artery embolization*1Obstetrics & Gynecology, 2002